VCs Warming To Diagnostics As Personalized Medicine Appears On Horizon
This article was originally published in The Gray Sheet
Executive Summary
Diagnostic firms are gaining favor in venture capitalist circles as healthcare moves toward targeted medicine, according to BioAdvance Ventures Managing Director Gary Kurtzman, MD